journal article·2023-04-26

Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction

Danping Wang, Lingxiao Li, Hezhen Xu, Yixin Sun, Wenxiao Li, Tian Liu, Yan Li, Xianbao Shi, Zhonggui He, Yinglei Zhai, Bingjun Sun, Jin Sun

Nano Letters· Volume 23· Issue 8
Publisher page

Abstract

Prodrug-based nanoassemblies have been developed to solve the bottlenecks of chemotherapeutic drugs. The fabricated prodrugs usually consist of active drug modules, response modules, and modification modules. Among three modules, the response modules play a vital role in controlling the intelligent drug release at tumor sites. Herein, various locations of disulfide bond linkages were selected as response modules to construct three Docetaxel (DTX) prodrugs. Interestingly, the small structural difference caused by the length of response modules endowed corresponding prodrug nanoassemblies with unique characteristic. α-DTX-OD nanoparticles (NPs) possessed the advantages of high redox-responsiveness due to their shortest linkages. However, they were too sensitive to retain the intact structure in the blood circulation, leading to severe systematic toxicity. β-DTX-OD NPs significantly improved the pharmacokinetics of DTX but may induce damage to the liver. In comparison, γ-DTX-OD NPs with the longest linkages greatly ameliorated the delivery efficiency of DTX as well as improved DTX's tolerance dose.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Transport and Resistance Mechanisms · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China

Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong 264000, China

Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China

School of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China

Funding

Ministry of Science and Technology of the People's Republic of China · Doctoral Start-up Foundation of Liaoning Province · Department of Education of Liaoning Province · National Natural Science Foundation of China · Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program

References (28)

Show source-provided references
1. 10.1016/j.cclet.2021.11.05610.1016/j.cclet.2021.11.056 ↗
2. 10.1002/cncr.1188210.1002/cncr.11882 ↗
3. 10.1158/0008-5472.CAN-06-391410.1158/0008-5472.CAN-06-3914 ↗
4. 10.1007/s12282-016-0677-410.1007/s12282-016-0677-4 ↗
5. 10.1007/s10867-014-9369-510.1007/s10867-014-9369-5 ↗
6. 10.1016/S0140-6736(22)00367-110.1016/S0140-6736(22)00367-1 ↗
7. 10.1073/pnas.05130939810.1073/pnas.051309398 ↗
8. 10.1002/cmdc.20120005210.1002/cmdc.201200052 ↗
9. 10.1016/j.ijpharm.2009.06.00410.1016/j.ijpharm.2009.06.004 ↗
10. Sampath D. · MOLECULAR CANCER THERAPEUTICS · 2003 · 2 · 873
11. 10.1016/j.jconrel.2017.03.02710.1016/j.jconrel.2017.03.027 ↗
12. 10.1517/17425247.2012.69660610.1517/17425247.2012.696606 ↗
13. 10.1080/17425247.2019.158364410.1080/17425247.2019.1583644 ↗
14. 10.1016/j.ijpharm.2018.08.04110.1016/j.ijpharm.2018.08.041 ↗
15. 10.1002/ejlt.20200033710.1002/ejlt.202000337 ↗
16. 10.1016/j.addr.2022.11417710.1016/j.addr.2022.114177 ↗
17. 10.1126/sciadv.abc172510.1126/sciadv.abc1725 ↗
18. 10.1007/s12274-021-3895-910.1007/s12274-021-3895-9 ↗
19. 10.1016/j.jconrel.2017.08.03410.1016/j.jconrel.2017.08.034 ↗
20. 10.1002/smll.20200503910.1002/smll.202005039 ↗
21. 10.1038/s41467-022-35033-710.1038/s41467-022-35033-7 ↗
22. 10.1016/j.jconrel.2021.02.03010.1016/j.jconrel.2021.02.030 ↗
23. 10.1016/j.ajps.2021.02.00210.1016/j.ajps.2021.02.002 ↗
24. 10.1002/adhm.20210140710.1002/adhm.202101407 ↗
25. 10.1016/j.colsurfb.2018.08.06810.1016/j.colsurfb.2018.08.068 ↗
26. 10.1021/acs.nanolett.8b0073710.1021/acs.nanolett.8b00737 ↗
27. 10.1021/acsami.2c1452310.1021/acsami.2c14523 ↗
28. 10.1016/j.fct.2019.11084010.1016/j.fct.2019.110840 ↗